Characteristics of study patients
| Patient no. | Sex | Age (y) | Genotype |
No of MRSA isolates | Treatment given | Colonised >3 months |
| 1 | F | 6 | ΔF508/N1303K | 30 | Teicoplanin (iv) | Yes |
| 2 | F | 11 | ΔF508/ΔF508 | 11 | Clindamycin | Yes |
| 3 | F | 2.5 | ΔF508/ΔF508 | 2 | Vancomycin (neb) | No |
| 4 | F | 11 | ΔF508/ΔF508 | 3 | None | Yes |
| 5 | F | 12 | ΔF508/ΔF508 | 6 | Vancomycin (neb) | Yes |
| 6 | M | 15 | G542X/1154insTC | 1 | Fucidic acid | No |
| 7 | M | 7 | ΔF508/? | 2 | Clindamycin | No |
| 8 | M | 10 | ΔF508/? | 7 | Vancomycin (iv) | Yes |
| 9 | M | 6 | ΔF508/ΔF508 | 2 | Vancomycin (neb) | No |
| 10 | M | 11 | ΔF508/ΔF508 | 1 | Vancomycin (iv) | No |